213 related articles for article (PubMed ID: 34381053)
1. Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia.
Consonni M; Garavaglia C; Grilli A; de Lalla C; Mancino A; Mori L; De Libero G; Montagna D; Casucci M; Serafini M; Bonini C; Häussinger D; Ciceri F; Bernardi M; Mastaglio S; Bicciato S; Dellabona P; Casorati G
Nat Commun; 2021 Aug; 12(1):4844. PubMed ID: 34381053
[TBL] [Abstract][Full Text] [Related]
2. A novel self-lipid antigen targets human T cells against CD1c(+) leukemias.
Lepore M; de Lalla C; Gundimeda SR; Gsellinger H; Consonni M; Garavaglia C; Sansano S; Piccolo F; Scelfo A; Häussinger D; Montagna D; Locatelli F; Bonini C; Bondanza A; Forcina A; Li Z; Ni G; Ciceri F; Jenö P; Xia C; Mori L; Dellabona P; Casorati G; De Libero G
J Exp Med; 2014 Jun; 211(7):1363-77. PubMed ID: 24935257
[TBL] [Abstract][Full Text] [Related]
3. HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.
van Balen P; Jedema I; van Loenen MM; de Boer R; van Egmond HM; Hagedoorn RS; Hoogstaten C; Veld SAJ; Hageman L; van Liempt PAG; Zwaginga JJ; Meij P; Veelken H; Falkenburg JHF; Heemskerk MHM
Front Immunol; 2020; 11():1804. PubMed ID: 32973756
[TBL] [Abstract][Full Text] [Related]
4. Harnessing the CD1 restricted T cell response for leukemia adoptive immunotherapy.
Consonni M; de Lalla C; Bigi A; Dellabona P; Casorati G
Cytokine Growth Factor Rev; 2017 Aug; 36():117-123. PubMed ID: 28712863
[TBL] [Abstract][Full Text] [Related]
5. Donor-unrestricted T cells in the human CD1 system.
Huang S; Moody DB
Immunogenetics; 2016 Aug; 68(8):577-96. PubMed ID: 27502318
[TBL] [Abstract][Full Text] [Related]
6. T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids.
Wun KS; Reijneveld JF; Cheng TY; Ladell K; Uldrich AP; Le Nours J; Miners KL; McLaren JE; Grant EJ; Haigh OL; Watkins TS; Suliman S; Iwany S; Jimenez J; Calderon R; Tamara KL; Leon SR; Murray MB; Mayfield JA; Altman JD; Purcell AW; Miles JJ; Godfrey DI; Gras S; Price DA; Van Rhijn I; Moody DB; Rossjohn J
Nat Immunol; 2018 Apr; 19(4):397-406. PubMed ID: 29531339
[TBL] [Abstract][Full Text] [Related]
7. Anti-human CD117 CAR T-cells efficiently eliminate healthy and malignant CD117-expressing hematopoietic cells.
Myburgh R; Kiefer JD; Russkamp NF; Magnani CF; Nuñez N; Simonis A; Pfister S; Wilk CM; McHugh D; Friemel J; Müller AM; Becher B; Münz C; van den Broek M; Neri D; Manz MG
Leukemia; 2020 Oct; 34(10):2688-2703. PubMed ID: 32358567
[TBL] [Abstract][Full Text] [Related]
8. Donor Unrestricted T Cells: A Shared Human T Cell Response.
Van Rhijn I; Moody DB
J Immunol; 2015 Sep; 195(5):1927-32. PubMed ID: 26297792
[TBL] [Abstract][Full Text] [Related]
9. CD36 family members are TCR-independent ligands for CD1 antigen-presenting molecules.
Gherardin NA; Redmond SJ; McWilliam HEG; Almeida CF; Gourley KHA; Seneviratna R; Li S; De Rose R; Ross FJ; Nguyen-Robertson CV; Su S; Ritchie ME; Villadangos JA; Moody DB; Pellicci DG; Uldrich AP; Godfrey DI
Sci Immunol; 2021 Jun; 6(60):. PubMed ID: 34172588
[TBL] [Abstract][Full Text] [Related]
10. CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family.
Beckman EM; Melián A; Behar SM; Sieling PA; Chatterjee D; Furlong ST; Matsumoto R; Rosat JP; Modlin RL; Porcelli SA
J Immunol; 1996 Oct; 157(7):2795-803. PubMed ID: 8816382
[TBL] [Abstract][Full Text] [Related]
11. HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation.
Herr W; Eichinger Y; Beshay J; Bloetz A; Vatter S; Mirbeth C; Distler E; Hartwig UF; Thomas S
Leukemia; 2017 Feb; 31(2):434-445. PubMed ID: 27479183
[TBL] [Abstract][Full Text] [Related]
12. Off-the-Shelf Allogeneic T Cell Therapies for Cancer: Opportunities and Challenges Using Naturally Occurring "Universal" Donor T Cells.
Perez C; Gruber I; Arber C
Front Immunol; 2020; 11():583716. PubMed ID: 33262761
[TBL] [Abstract][Full Text] [Related]
13. Isolation and Characterization of an HLA-DRB1*04-Restricted HPV16-E7 T Cell Receptor for Cancer Immunotherapy.
Mercier-Letondal P; Marton C; Deschamps M; Ferrand C; Vauchy C; Chenut C; Baguet A; Adotévi O; Borg C; Galaine J; Godet Y
Hum Gene Ther; 2018 Oct; 29(10):1202-1212. PubMed ID: 30136612
[TBL] [Abstract][Full Text] [Related]
14. The in vitro generation of multi-tumor antigen-specific cytotoxic T cell clones: Candidates for leukemia adoptive immunotherapy following allogeneic stem cell transplantation.
Mohamed YS; Bashawri LA; Vatte C; Abu-Rish EY; Cyrus C; Khalaf WS; Browning MJ
Mol Immunol; 2016 Sep; 77():79-88. PubMed ID: 27490939
[TBL] [Abstract][Full Text] [Related]
15. CD1a and CD1c activate intrathyroidal T cells during Graves' disease and Hashimoto's thyroiditis.
Roura-Mir C; Catálfamo M; Cheng TY; Marqusee E; Besra GS; Jaraquemada D; Moody DB
J Immunol; 2005 Mar; 174(6):3773-80. PubMed ID: 15749918
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform.
Magnani CF; Turazzi N; Benedicenti F; Calabria A; Tenderini E; Tettamanti S; Giordano Attianese GM; Cooper LJ; Aiuti A; Montini E; Biondi A; Biagi E
Oncotarget; 2016 Aug; 7(32):51581-51597. PubMed ID: 27323395
[TBL] [Abstract][Full Text] [Related]
17. A Subset of Human Autoreactive CD1c-Restricted T Cells Preferentially Expresses TRBV4-1
Guo T; Koo MY; Kagoya Y; Anczurowski M; Wang CH; Saso K; Butler MO; Hirano N
J Immunol; 2018 Jan; 200(2):500-511. PubMed ID: 29237773
[TBL] [Abstract][Full Text] [Related]
18. CD1c tetramers detect ex vivo T cell responses to processed phosphomycoketide antigens.
Ly D; Kasmar AG; Cheng TY; de Jong A; Huang S; Roy S; Bhatt A; van Summeren RP; Altman JD; Jacobs WR; Adams EJ; Minnaard AJ; Porcelli SA; Moody DB
J Exp Med; 2013 Apr; 210(4):729-41. PubMed ID: 23530121
[TBL] [Abstract][Full Text] [Related]
19. Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease.
Chang YJ; Zhao XY; Huang XJ
Front Immunol; 2018; 9():3041. PubMed ID: 30619371
[TBL] [Abstract][Full Text] [Related]
20. Lipid and small-molecule display by CD1 and MR1.
Van Rhijn I; Godfrey DI; Rossjohn J; Moody DB
Nat Rev Immunol; 2015 Oct; 15(10):643-54. PubMed ID: 26388332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
